🔎 Trials Near Me

Akèy › Kansè pwostat › Montana › Billings

Etid klinik pou Kansè pwostat nan Billings, MT

15 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Billings (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Ap rekriteFaz 3
  • Billings Clinic Cancer Center, Billings
  • Saint Vincent Frontier Cancer Center, Billings
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Ap rekriteFaz 3
  • Billings Clinic Cancer Center, Billings
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Billings Clinic Cancer Center, Billings
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Ap rekriteFaz 2
  • Billings Clinic Cancer Center, Billings
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Billings Clinic Cancer Center, Billings
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Ap rekriteFaz 3
  • St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06136650

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Ap rekriteFaz 3
  • St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT06925737

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Ap rekriteFaz 3
  • Billings Clinic Cancer Center, Billings
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Ap rekriteFaz 3
  • Billings Clinic Cancer Center, Billings
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Ap rekriteFaz 3
  • Billings Clinic Cancer Center, Billings
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

Ap rekriteFaz 3
  • Billings Clinic Cancer Center, Billings
Laj 18 ak plis · Gason · Mizajou Apr 14, 2026 · NCT06235697

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Ap rekriteFaz 2
  • Billings Clinic Cancer Center, Billings
Laj 18 ak plis · Gason · Mizajou Jan 29, 2026 · NCT05806515

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Billings
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Ap rekriteFaz 3
  • Billings Clinic Cancer Center, Billings
Laj 18 ak plis · Gason · Mizajou Sep 11, 2025 · NCT03678025

Etid Kansè pwostat nan lòt vil

Lòt etid nan Billings

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.